These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30262246)

  • 1. No evidence found for an increased risk of long-term fatigue following human papillomavirus vaccination of adolescent girls.
    Schurink-Van't Klooster TM; Kemmeren JM; van der Maas NAT; van de Putte EM; Ter Wolbeek M; Nijhof SL; Vanrolleghem AM; van Vliet JA; Sturkenboom M; de Melker HE
    Vaccine; 2018 Oct; 36(45):6796-6802. PubMed ID: 30262246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway.
    Feiring B; Laake I; Bakken IJ; Greve-Isdahl M; Wyller VB; Håberg SE; Magnus P; Trogstad L
    Vaccine; 2017 Jul; 35(33):4203-4212. PubMed ID: 28648542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital Records of Pain, Fatigue, or Circulatory Symptoms in Girls Exposed to Human Papillomavirus Vaccination: Cohort, Self-Controlled Case Series, and Population Time Trend Studies.
    Thomsen RW; Öztürk B; Pedersen L; Nicolaisen SK; Petersen I; Olsen J; Sørensen HT
    Am J Epidemiol; 2020 Apr; 189(4):277-285. PubMed ID: 31899791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UK.
    Donegan K; Beau-Lejdstrom R; King B; Seabroke S; Thomson A; Bryan P
    Vaccine; 2013 Oct; 31(43):4961-7. PubMed ID: 24001935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reported adverse events in girls aged 13-16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands.
    van Klooster TM; Kemmeren JM; van der Maas NA; de Melker HE
    Vaccine; 2011 Jun; 29(28):4601-7. PubMed ID: 21549785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infections in temporal proximity to HPV vaccination and adverse effects following vaccination in Denmark: A nationwide register-based cohort study and case-crossover analysis.
    Krogsgaard LW; Petersen I; Plana-Ripoll O; Bech BH; Lützen TH; Thomsen RW; Rytter D
    PLoS Med; 2021 Sep; 18(9):e1003768. PubMed ID: 34495975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2million young girls in France.
    Miranda S; Chaignot C; Collin C; Dray-Spira R; Weill A; Zureik M
    Vaccine; 2017 Aug; 35(36):4761-4768. PubMed ID: 28750853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study.
    Yoon D; Lee JH; Lee H; Shin JY
    BMJ; 2021 Jan; 372():m4931. PubMed ID: 33514507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining a possible association between human papilloma virus (HPV) vaccination and migraine: results of a cohort study in the Netherlands.
    Schurink-Van't Klooster TM; de Ridder MA; Kemmeren JM; van der Lei J; Dekker F; Sturkenboom M; de Melker HE
    Eur J Pediatr; 2015 May; 174(5):641-9. PubMed ID: 25367054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system.
    Scheller NM; Svanström H; Pasternak B; Arnheim-Dahlström L; Sundström K; Fink K; Hviid A
    JAMA; 2015 Jan; 313(1):54-61. PubMed ID: 25562266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of adverse events with bivalent human papilloma virus vaccination: A nationwide register-based cohort study in Finland.
    Skufca J; Ollgren J; Artama M; Ruokokoski E; Nohynek H; Palmu AA
    Vaccine; 2018 Sep; 36(39):5926-5933. PubMed ID: 30115524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase
    Chandler RE; Juhlin K; Fransson J; Caster O; Edwards IR; Norén GN
    Drug Saf; 2017 Jan; 40(1):81-90. PubMed ID: 27638661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cluster analysis of serious adverse event reports after human papillomavirus (HPV) vaccination in Danish girls and young women, September 2009 to August 2017.
    Ward D; Thorsen NM; Frisch M; Valentiner-Branth P; Mølbak K; Hviid A
    Euro Surveill; 2019 May; 24(19):. PubMed ID: 31088598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination Against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients.
    Woestenberg PJ; Guevara Morel AE; Bogaards JA; Hooiveld M; Schurink-van 't Klooster TM; Hoebe CJPA; van der Sande MAB; van Benthem BHB
    Clin Infect Dis; 2021 Jul; 73(2):291-297. PubMed ID: 32421775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reports of Postural Orthostatic Tachycardia Syndrome After Human Papillomavirus Vaccination in the Vaccine Adverse Event Reporting System.
    Arana J; Mba-Jonas A; Jankosky C; Lewis P; Moro PL; Shimabukuro TT; Cano M
    J Adolesc Health; 2017 Nov; 61(5):577-582. PubMed ID: 29061232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health care utilization in general practice after HPV vaccination-A Danish nationwide register-based cohort study.
    Krogsgaard LW; Vestergaard CH; Plana-Ripoll O; Lützen TH; Vestergaard M; Fenger-Grøn M; Bech BH; Rytter D
    PLoS One; 2017; 12(9):e0184658. PubMed ID: 28886180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events from HPV vaccination in Taiwan.
    Tsai SA; Lu CY; Chen TI; Huang SP; Chen YC
    Vaccine; 2023 Nov; 41(49):7444-7449. PubMed ID: 37949754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serious adverse events after HPV vaccination: a critical review of randomized trials and post-marketing case series.
    Martínez-Lavín M; Amezcua-Guerra L
    Clin Rheumatol; 2017 Oct; 36(10):2169-2178. PubMed ID: 28730271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.
    Chow EPF; Machalek DA; Tabrizi SN; Danielewski JA; Fehler G; Bradshaw CS; Garland SM; Chen MY; Fairley CK
    Lancet Infect Dis; 2017 Jan; 17(1):68-77. PubMed ID: 27282422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.